Edition:
India

Alnylam Completes Rolling Submission Of NDA To U.S. FDa For Givosiran For The Treatment Of Acute Hepatic Porphyria


Wednesday, 5 Jun 2019 

June 5 (Reuters) - Alnylam Pharmaceuticals Inc ::ALNYLAM COMPLETES ROLLING SUBMISSION OF NEW DRUG APPLICATION TO U.S. FOOD AND DRUG ADMINISTRATION (FDA) FOR GIVOSIRAN FOR THE TREATMENT OF ACUTE HEPATIC PORPHYRIA.